J. R. González-Juanatey

发表

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial

P. Ponikowski, I. Piña, G. Filippatos, 2020, European Journal of Heart Failure.

20 years of leptin: Role of leptin in cardiomyocyte physiology and physiopathology.

E. Roselló-Lletí, M. Rivera, M. Portolés, 2015, Life sciences.

Markers of Inflammation and Cardiovascular Disease

Vicente Bertomeu Martínez, J. González-Juanatey, J. Ramón González-Juanatey, 2009, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Real world comparison of the MGuard Stent versus the bare metal stent for ST Elevation myocardial infarction (The REWARD‐MI study)

J. González-Juanatey, B. Cid-Álvarez, R. Trillo-Nouche, 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function

J. González-Juanatey, J. García-Acuña, L. G. Shamagian, 2005, Heart.

Heart failure in patients with preserved and deteriorated left ventricular ejection fraction

J. González-Juanatey, A. Varela-Román, L. Grigorian, 2005, Heart.

Mehran contrast nephropathy risk score: Is it still useful 10 years later?

S. Raposeiras-Roubín, E. Abu-Assi, J. González-Juanatey, 2016, Journal of cardiology.

Atrial fibrillation ablation in patients with arrhythmia‐induced cardiomyopathy: a prospective multicentre study

A. Sarkozy, C. Minguito-Carazo, M. Rodríguez-Mañero, 2023, ESC heart failure.

The use of the CNIC-Polypill in real-life clinical practice: opportunities and challenges in patients at very high risk of atherosclerotic cardiovascular disease – expert panel meeting report

J. Morais, P. Pérez-Martínez, R. Kreutz, 2023, BMC Proceedings.

Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension

G. Filippatos, L. Lund, M. Metra, 2023, European journal of heart failure.

Clinical Benefit of Bempedoic Acid in Randomized Clinical Trials.

J. Badimón, J. Castellano, L. Fácila, 2023, American Journal of Cardiology.

Prevention of myocardial infarction and stroke with PCSK9 inhibitors treatment: a metanalysis of recent randomized clinical trials

J. González-Juanatey, L. Fácila, A. Cordero, 2020, Journal of Diabetes & Metabolic Disorders.

The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events.

J. Badimón, G. Vilahur, L. Badimón, 2023, Journal of clinical lipidology.

Effect of PCSK9 inhibitors on remnant cholesterol and lipid residual risk: The LIPID‐REAL registry

J. González-Juanatey, L. Fácila, J. Bañeras, 2022, European journal of clinical investigation.

Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial

P. Ponikowski, G. Filippatos, M. Senni, 2020, European Journal of Heart Failure.

Plasma FABP4 levels are associated with left atrial fat volume in persistent atrial fibrillation and predict recurrence after catheter ablation.

J. González-Juanatey, M. Couselo-Seijas, S. Eiras, 2019, International journal of cardiology.

Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.

J. González-Juanatey, J. García-Acuña, A. P. Reino, 1998, The American journal of cardiology.